Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Sirtris Pharmaceuticals

2004 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
$720M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of proprietary, orally administrable, small molecule biopharmaceutical drugs by manipulating sirtuins.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 790 Memorial Drive
  • Cambridge, MA 02139
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Sirtris Pharmaceuticals’s full profile, request a free trial.

Sirtris Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 06-Jun-2008 $720M 00000 00000 Completed Clinical Trials - Phase 1
7. IPO 23-May-2007 0000 00000 00000 Completed Clinical Trials - Phase 1
6. Later Stage VC (Series C1) 06-Feb-2007 0000 00000 00000 Completed Generating Revenue
5. Debt - General 19-Apr-2006 0000 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 04-Apr-2006 000.00 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series B) 08-Mar-2005 000.00 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series A1) 01-Dec-2004 $13M $18M 000.00 Completed Product Development
1. Early Stage VC (Series A) 09-Sep-2004 $5M $5M 00.000 Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Sirtris Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C1 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00.0 00.0 00 00.0 00.000
Series A1 21,666,667 $0.001000 $0.6 $0.6 1x $0.6 19.73%
Series A 10,000,000 $0.001000 $0.5 $0.5 1x $0.5 9.1%
To view this company’s complete Cap Table, request access »

Sirtris Pharmaceuticals Former Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Bessemer Venture Partners Venture Capital Minority 000 0000 000000 0
Bock Family Ventures Venture Capital Minority 000 0000 000000 0
Cardinal Partners Venture Capital Minority 000 0000 000000 0
Cargill Ventures Corporate Venture Capital Minority 000 0000 000000 0
Cycad Group Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »

Sirtris Pharmaceuticals Executive Team (2)

Name Title Board
Seat
Contact
Info
Paul Schimmel Ph.D Member of Scientific Advisory Board

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »